Home > List of Issue > Table of Contents > Abstract

Journal of Nippon Medical School

Full Text of this Article

-Original-

Dextran Sulfate and Stromal Cell Derived Factor-1 Promote CXCR4 Expression and Improve Bone Marrow Homing Efficiency of Infused Hematopoietic Stem Cells

Jun Hayakawa1, Makoto Migita1-3, Takahiro Ueda1, Ryuji Fukazawa1, Kumi Adachi2,3, Yuki Ooue1, Mari Hayakawa1, Takashi Shimada2,3 and Yoshitaka Fukunaga1

1Department of Pediatrics, Graduate School of Medicine, Nippon Medical School
2Department of Molecular and Medical Genetics, Graduate School of Medicine, Nippon Medical School
3Division of Gene Therapy Research, Center for Advanced Medical Technology


Although the homing of hematopoietic stem cells (HSC) to the bone marrow (BM) is a crucial step in hematopoietic development and BM repopulation, the mechanisms underlying these processes have not been fully clarified. Recent studies suggest that interaction between the chemokine receptor CXCR4 and its ligand, stromal cell-derived factor 1 (SDF-1), plays a critical role in these processes. In addition, dextran sulfate increases plasma SDF-1 levels in mice and nonhuman primates. Thus, we examined the effects of preconditioning with SDF-1 and dextran sulfate on the homing efficiency of HSCs following BM transplantation in mice. We found that the preconditioning of donor mice with either SDF-1 or dextran sulfate enhanced the homing efficiency of infused HSCs in vivo. The greatest effects were obtained with dextran sulfate. Moreover, reverse transcriptase polymerase chain reaction analysis demonstrated that SDF-1 and dextran sulfate increased transcription of a variety of homing-related genes, including those for CXCR4, lymphocyte function associated antigen-1, matrix metalloproteinase-9, very late antigen-4/5, and macrophage inflammatory protein-1. We suggest that whereas SDF-1 directly acts to upregulate CXCR4 expression in HSCs, dextran sulfate acts via multiple pathways involved in the induction of various homing-related molecules, in addition to SDF-1. Thus, preconditioning donors with dextran sulfate offers a novel clinical approach for improving the homing and engraftment of HSCs in the BM.

J Nippon Med Sch 2009; 76: 198-208

Keywords
stromal cell-derived factor 1, dextran sulfate, CXCR4, bone marrow transplantation, hematopoietic stem cells

Correspondence to
Makoto Migita, MD, PhD, Department of Pediatrics, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
mmigita@nms.ac.jp

Received, February 21, 2008
Accepted, March 23, 2009